Subscribe to our Newsletters !!

    Kumar Jeetendra

    Failsafe monitor to shut off your HPLC if a solvent reservoir runs dry

    The Solvent Line Monitor from TESTA Analytical is a true plug-and-play addition to any HPLC system designed to detect when one or more of its pump solvent reservoirs are empty and automatically shut-off the system. Modern chromatography systems often include automation enabling them to achieve a high sample throughput which was unthinkable just a few

    Extruded Profiles – (Silicone/Viton®/EPDM)

    APPL offers a wide range of Silicone Extruded Gaskets in more than 1000 different shapes and designs (In round and square types). APPL’s extruded gaskets (Autoclave) are made from Food-Pharma Grade pure silicone rubber which can easily withstands a temperature range of -80°C to +250°C. Extruded Gaskets are available in square cross sections like 6mm

    Cipla’s Indore plant joins the World Economic Forum’s (WEF) prestigious Lighthouse Network

    Cipla Limited (BSE: 500087; NSE: CIPLA EQ) (“Cipla”) today announced that its Indore Oral Solid Dosage (OSD) plant has been designated by the World Economic Forum as an ‘Advanced Fourth Industrial Revolution (4IR) Lighthouse’. This is the first Cipla facility to receive the coveted recognition. The organisation is amongst the first pharmaceutical companies in India

    An innovative concept of ‘precision medicine’ : The Sefam S.Box

    S.Box is much more than a treatment device; it is an innovative concept of ‘precision medicine’ that puts the patients at the center of their treatment. In addition to the innovations of this Auto-CPAP device, the S.Box is designed by a famous French designer Philippe Starck. The S.Box concept offers mobile apps and the use of some medical

    VINCOV-19, an antidote, and a cure against COVID-19, successfully completes Phase 2 Clinical Trials

    VINS Bioproducts Limited, a leading immunological company, based in Hyderabad, in collaboration with the Centre for Cellular and Molecular Biology (CCMB) and the University of Hyderabad (UoH), announced the successful completion of Phase 2 Clinical Trials of VINCOV-19, India’s first antidote and a cure against SARS-CoV-2 virus. VINCOV-19 is now ready for market authorization and

    Bringing to you one of our most informative Cell line development webinar, Watch this on-demand now

    Sartorius’ technologies are the most popular choice of labs globally for the early identification of stable, scalable, and high-titer cell lines. When it comes to the commercialization of a biological product, effective, high-quality cell line development is essential for your success. Join this webinar to learn how our high-throughput platforms – Octet®️, iQue®️, and Ambr®️15,

    Baxter strengthens its R&D capabilities with the inauguration of the global Pharmaceuticals R&D Centre in Ahmedabad, India

    Baxter Pharmaceuticals India Pvt. Ltd., today announced the inauguration of a global Pharmaceuticals R&D Centre in Ahmedabad, India. The Centre will help further the company’s mission of saving and sustaining lives by accelerating innovation in the generic and differentiated injectable pharmaceuticals space. The R&D Centre was inaugurated by Mr. Alok Sonig, President, Pharmaceuticals, Baxter International Inc.

    Parexel Recognized by Frost & Sullivan with 2022 Global Customer Value Leadership Award

    Based on its recent analysis of the global decentralized clinical trials (DCT) industry, Frost & Sullivan has recognized leading global clinical research organization (CRO) Parexel with the 2022 Global Customer Value Leadership Award. Parexel combines in-house expertise, patient and caregiver insights, and cutting-edge technologies to plan, operationalize, and deliver DCTs for biopharmaceutical customers worldwide while

    Aragen to operationalize cutting-edge formulation manufacturing facility

     Aragen, a leading Contract Research Development and Manufacturing Organization (CRDMO), today announced that it will operationalize its state-of-the-art formulation manufacturing facility in the Mallapur campus, Hyderabad, India by January 2023. The 12,000 square feet new facility will strengthen the company’s ability to deliver clinical supplies to customers through its integrated drug substance and drug product

    Alembic Pharmaceuticals announces its first injectable product approval from its General Sterile Facility – Final Approval for Glycopyrrolate Injection USP

    Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Glycopyrrolate Injection USP, 0.2 mg/1 mL and 0.4 mg/2 mL (0.2 mg/mL) Single-dose Vials and 1 mg/5 mL (0.2 mg/mL) and 4 mg/20 mL (0.2 mg/mL) Multiple-dose Vials.